CATALOGO DEI PRODOTTI DELLA RICERCA

MARASTONI, DAMIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.736
NA - Nord America 1.422
AS - Asia 1.209
SA - Sud America 242
AF - Africa 68
OC - Oceania 5
Totale 4.682
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.360
RU - Federazione Russa 908
SG - Singapore 461
CN - Cina 292
IT - Italia 205
BR - Brasile 200
HK - Hong Kong 127
GB - Regno Unito 126
DE - Germania 97
VN - Vietnam 93
FI - Finlandia 84
SE - Svezia 79
FR - Francia 75
IE - Irlanda 65
TR - Turchia 56
KR - Corea 41
CA - Canada 37
ID - Indonesia 32
NL - Olanda 22
JP - Giappone 19
IN - India 18
MX - Messico 18
AT - Austria 17
PL - Polonia 16
EG - Egitto 15
TG - Togo 15
BJ - Benin 14
AR - Argentina 13
BD - Bangladesh 11
ZA - Sudafrica 11
IR - Iran 10
UA - Ucraina 10
CO - Colombia 8
ES - Italia 8
EC - Ecuador 6
IQ - Iraq 6
AZ - Azerbaigian 5
BE - Belgio 5
PY - Paraguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
LA - Repubblica Popolare Democratica del Laos 4
PK - Pakistan 4
AU - Australia 3
HR - Croazia 3
IL - Israele 3
KZ - Kazakistan 3
PE - Perù 3
RS - Serbia 3
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GY - Guiana 2
KE - Kenya 2
LT - Lituania 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SC - Seychelles 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 4.682
Salva come PNG Salva come JPEG
Città #
Moscow 332
Chandler 204
Ashburn 190
Dallas 187
Singapore 165
Hong Kong 127
Verona 75
Dublin 63
Beijing 62
Southend 59
Helsinki 47
New York 43
Los Angeles 42
Redmond 39
Istanbul 38
Munich 36
Princeton 29
São Paulo 29
Jakarta 27
Lappeenranta 24
London 23
Jacksonville 22
Lawrence 22
Ho Chi Minh City 21
Dong Ket 20
Montreal 20
The Dalles 20
Redondo Beach 18
Buffalo 17
Sindelfingen 16
Tokyo 16
Lomé 15
Warsaw 15
Cotonou 14
Milan 14
Columbus 13
Poplar 13
Amsterdam 12
Hanoi 12
Nuremberg 12
Turku 12
Wilmington 12
Brooklyn 11
Chicago 11
Jinan 11
Santa Clara 11
Woodbridge 11
Atlanta 10
Council Bluffs 10
Phoenix 10
Seattle 10
Stockholm 10
Tianjin 10
Ankara 9
Denver 9
Ann Arbor 8
Chennai 8
Houston 8
Johannesburg 8
Vienna 8
Washington 8
Bologna 7
East Lansing 7
Falkenstein 7
Guangzhou 7
Mexico City 7
Redwood City 7
Taizhou 7
Toronto 7
Cairo 6
Chirignago 6
Haiphong 6
Manchester 6
Nanjing 6
Querétaro 6
San Francisco 6
Seoul 6
Baku 5
Dhaka 5
Duncan 5
Norwalk 5
Paris 5
Porto Alegre 5
Rio de Janeiro 5
Rome 5
Shenyang 5
Taiyuan 5
Zhengzhou 5
Biên Hòa 4
Brussels 4
Dongguan 4
Fairfield 4
Frankfurt am Main 4
Guarulhos 4
Hebei 4
Pordenone 4
Sommacampagna 4
Tashkent 4
Treviso 4
Baghdad 3
Totale 2.564
Salva come PNG Salva come JPEG
Nome #
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 179
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 175
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 170
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 160
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 154
IMMUNOPATHOLOGY OF INTRATHECAL INFLAMMATION IN MULTIPLE SCLEROSIS: CLINICAL, RADIOLOGICAL AND IMMUNOLOGICAL CORRELATES 147
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 139
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 138
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 135
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 135
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 131
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 128
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 126
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 123
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 122
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 119
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 117
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 114
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 108
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 108
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 107
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 105
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 103
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 103
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 100
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 99
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 97
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 95
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 94
Sustained response to subcutaneous immunoglobulins in chronic ataxic neuropathy with anti-disialosyl IgM antibodies (CANDA): report of two cases and review of the literature 93
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 92
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 91
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 89
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 88
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 82
The effect of air pollution on {COVID}-19 severity in a sample of patients with multiple sclerosis 81
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 81
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 75
The BAFF / APRIL system as therapeutic target in multiple sclerosis 75
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis 71
Prominent role of executive functioning on the Phonemic Fluency Test in people with multiple sclerosis 55
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 53
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 50
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 48
Totale 4.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.744
article - articoli 18.119
book - libri 0
conference - conferenze 355
curatela - curatele 0
other - altro 270
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.488
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 19 11 7 2 9 1 18 24
2021/2022217 6 65 0 51 2 1 9 10 5 19 11 38
2022/2023505 33 74 34 93 29 113 5 38 60 3 11 12
2023/2024354 11 20 22 53 29 71 24 13 6 33 58 14
2024/20251.258 55 75 53 212 60 68 85 88 178 76 87 221
2025/20262.175 219 200 221 655 880 0 0 0 0 0 0 0
Totale 4.755